Archived
This content is available here strictly for research, reference, and/or recordkeeping and as such it may not be fully accessible. If you work or study at University of Kentucky and would like to request an accessible version, please use the SensusAccess Document Converter.
Anti-Idiotype Monoclonal Antibody 1A7 and Use for the Treatment of Melanoma and Small Cell Carcinoma
US Patent Number
5612030
Publication Date
3-18-1997
Abstract
The present invention relates isolation of anti-idiotypic antibody 1A7 raised against anti-GD2 mAb 14G2a and its use for the treatment of melanoma and small cell carcinoma. The antibody may be used as a substitute for isolated purified GD2 antigen in any appropriate application.
Assignees
University of Kentucky Research Foundation, Lexington, Ky.
Application Number
372,676
Filing Date
01/17/1995
Recommended Citation
Chatterjee, Malaya and Foon, Kenneth A., "Anti-Idiotype Monoclonal Antibody 1A7 and Use for the Treatment of Melanoma and Small Cell Carcinoma" (1997). Microbiology, Immunology and Molecular Genetics Faculty Patents. 2.
https://uknowledge.uky.edu/microbio_patents/2
